Limitations of Caspofungin in Treating Candida Infections
Author Information
Author(s): Silke Schelenz, Calum N Ross
Primary Institution: Norfolk and Norwich University Hospital, UK
Hypothesis
What is the clinical efficacy of caspofungin in treating obstructive pyonephrosis due to Candida glabrata?
Conclusion
Caspofungin alone is insufficient for treating obstructive pyonephrosis caused by Candida glabrata, and local drainage combined with antifungal instillation is necessary for a sustained cure.
Supporting Evidence
- Caspofungin is effective against some Candida species but not in all cases.
- Local drainage of pus is crucial for treating pyonephrosis.
- The patient had a history of azole-resistant Candida infections.
Takeaway
Caspofungin is not enough to treat certain kidney infections caused by a type of fungus; doctors need to drain the infection and use other medicines to help the patient get better.
Methodology
Case report detailing the treatment of a patient with obstructive pyonephrosis due to azole-resistant Candida glabrata.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
A 71-year-old female with type II diabetes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website